Date published: 2026-3-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

BAF250a Activators

BAF250a, also known by its gene name ARID1A, is a pivotal component of the SWI/SNF chromatin remodeling complex that plays a critical role in regulating gene expression by altering the chromatin structure. As a part of this complex, BAF250a facilitates access to DNA for transcription factors and, as a result, is integral to the transcriptional activation of various genes. The expression of BAF250a itself is subject to sophisticated control by a network of signaling pathways that reflect the cell's physiological state. In understanding the regulation of BAF250a, researchers have pinpointed a range of chemical compounds that can potentially upregulate the expression of this protein, shedding light on the intricate mechanics of gene regulation. These chemicals, often through epigenetic modifications or signaling cascades, can induce a more transcriptionally permissive environment around the ARID1A gene, thereby boosting BAF250a levels.

Among the chemicals that have been hypothesized to induce BAF250a expression are epigenetic modifiers like 5-Aza-2'-deoxycytidine and Trichostatin A, which target DNA methylation and histone acetylation, respectively. These compounds are thought to enhance the transcription of BAF250a by altering the chromatin landscape at the gene's promoter region, making it more accessible for transcriptional machinery. Other compounds, such as Forskolin and Sulforaphane, are believed to upregulate BAF250a through the activation of cellular signaling pathways that respond to environmental stimuli. Forskolin, for example, increases intracellular cAMP levels, which can lead to the activation of protein kinase A (PKA) and subsequent phosphorylation of transcription factors that drive BAF250a transcription. Similarly, Sulforaphane has been observed to stimulate antioxidant response elements that could enhance BAF250a expression as part of a cellular defensive mechanism. Compounds like Vitamin D3 and retinoic acid, which function as ligands for nuclear hormone receptors, also have the potential to upregulate BAF250a by binding to their respective receptors and modulating gene expression patterns, including those within the ARID1A locus. The diversity of these chemicals highlights the complex regulatory network that governs the expression of BAF250a and underscores the importance of broad-based approaches to study gene expression regulation.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

This compound may act as an HDAC inhibitor, potentially leading to hyperacetylation at the ARID1A locus and subsequent transcriptional activation of BAF250a.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

As a glucocorticoid, Dexamethasone could stimulate glucocorticoid receptors that bind to the ARID1A promoter region, potentially increasing BAF250a expression.